{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:13:33Z","timestamp":1792858413509,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004738","name":"E-Da Hospital","doi-asserted-by":"crossref","award":["EDAHT111005"],"award-info":[{"award-number":["EDAHT111005"]}],"id":[{"id":"10.13039\/501100004738","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taiwan National Science and Technology Council","award":["111-2314-B-214-003-MY3"],"award-info":[{"award-number":["111-2314-B-214-003-MY3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Non-typeable <jats:italic>Haemophilus influenzae<\/jats:italic> (NTHi) has become the major cause of invasive <jats:italic>H. influenzae<\/jats:italic> diseases in the post-<jats:italic>H. influenzae<\/jats:italic> type b vaccine era. The emergence of multidrug-resistant (MDR) NTHi is a growing public health problem. Herein, we investigated the molecular basis of MDR in NTHi. The isolated NTHi were subjected to antimicrobial susceptibility testing for 12 agents. Whole genome and plasmid sequencing were conducted and analyzed to identify significant genetic variations and plasmid-encoded genes conferred antibiotic resistance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirteen (50%) MDR NTHi isolates were obtained; of these, 92.3% were non-susceptible to ampicillin, 30.8% to amoxicillin-clavulanate, 61.5% to cefuroxime, 61.5% to ciprofloxacin\/levofloxacin, 92.3% to trimethoprim-sulfamethoxazole, 30.8% to tetracycline, and 7.7% to azithromycin. Eight ampicillin-resistant isolates were \u03b2-lactamase positive; of these, 6 carried <jats:italic>bla<\/jats:italic><jats:sub>TEM-1<\/jats:sub> and 2 carried <jats:italic>bla<\/jats:italic><jats:sub>ROB-1<\/jats:sub>, whereas 4 were \u03b2-lactamase negative. Genetic variations in <jats:italic>mrdA<\/jats:italic>, <jats:italic>mepA<\/jats:italic>, and <jats:italic>pbpG<\/jats:italic> were correlated with amoxicillin-clavulanate non-susceptibility, whereas variations in <jats:italic>ftsI<\/jats:italic> and <jats:italic>lpoA<\/jats:italic> conferred cefuroxime resistance. Five variations in <jats:italic>gyrA<\/jats:italic>, 2 in <jats:italic>gyrB<\/jats:italic>, 3 in <jats:italic>parC<\/jats:italic>, 1 in <jats:italic>parE<\/jats:italic>, and 1 in the <jats:italic>parC<\/jats:italic>-<jats:italic>parE<\/jats:italic> intergenic region were associated with levofloxacin\/ciprofloxacin non-susceptibility. Among these genes, 8 variations were linked to high-level levofloxacin resistance. Six variations in <jats:italic>folA<\/jats:italic> were associated with trimethoprim-sulfamethoxazole resistance. Plasmid-bearing <jats:italic>tet(B)<\/jats:italic> and <jats:italic>mef(A)<\/jats:italic> genes were responsible for tetracycline and azithromycin resistance in 4 and 1 MDR isolates, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study clarified the molecular epidemiology of MDR in NTHi. This can benefit the monitoring of drug resistance trends in NTHi and the adequate medical management of patients with NTHi infection.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12866-023-02926-6","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:02:50Z","timestamp":1688547770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole"],"prefix":"10.1186","volume":"23","author":[{"given":"Pei-Yi","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"2926_CR1","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00006454-200103000-00016","volume":"20","author":"PT Heath","year":"2001","unstructured":"Heath PT, Booy R, Azzopardi HJ, Slack MP, Fogarty J, Moloney AC, et al. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era. Pediatr Infect Dis J. 2001;20:300\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"2926_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3201\/eid1603.090290","volume":"16","author":"S Ladhani","year":"2010","unstructured":"Ladhani S, Slack MP, Heath PT, von Gottberg A, Chandra M, Ramsay ME, et al. Invasive Haemophilus influenzae Disease, Europe, 1996\u20132006. Emerg Infect Dis. 2010;16:455\u201363.","journal-title":"Emerg Infect Dis"},{"key":"2926_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1093\/cid\/ciy187","volume":"67","author":"HM Soeters","year":"2018","unstructured":"Soeters HM, Blain A, Pondo T, Doman B, Farley MM, Harrison LH, et al. Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009\u20132015. Clin Infect Dis. 2018;67:881\u20139.","journal-title":"Clin Infect Dis"},{"key":"2926_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cir268","volume":"53","author":"K van Wessel","year":"2011","unstructured":"van Wessel K, Rodenburg GD, Veenhoven RH, Spanjaard L, van der Ende A, Sanders EA. Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001\u20132008. Clin Infect Dis. 2011;53:e1-7.","journal-title":"Clin Infect Dis"},{"key":"2926_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/jcp.56.5.344","volume":"56","author":"LD Liebowitz","year":"2003","unstructured":"Liebowitz LD, Slabbert M, Huisamen A. National surveillance programme on susceptibility patterns of respiratory pathogens in South Africa: moxifloxacin compared with eight other antimicrobial agents. J Clin Pathol. 2003;56:344\u20137.","journal-title":"J Clin Pathol"},{"key":"2926_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ijantimicag.2004.09.016","volume":"25","author":"SE Beekmann","year":"2005","unstructured":"Beekmann SE, Heilmann KP, Richter SS, Garcia-de-Lomas J, Doern GV, Group GS. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int J Antimicrob Agents. 2005;25:148\u201356.","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 2","key":"2926_CR7","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/j.ijantimicag.2007.07.035","volume":"30","author":"C Alpuche","year":"2007","unstructured":"Alpuche C, Garau J, Lim V. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens. Int J Antimicrob Agents. 2007;30(Suppl 2):S135\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"2926_CR8","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1185\/03007990802381505","volume":"24","author":"WT Jansen","year":"2008","unstructured":"Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D. Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada. Curr Med Res Opin. 2008;24:2853\u201361.","journal-title":"Curr Med Res Opin"},{"key":"2926_CR9","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10156-008-0632-1","volume":"14","author":"K Gotoh","year":"2008","unstructured":"Gotoh K, Qin L, Watanabe K, Anh DD, Huong Ple T, Anh NT, et al. Prevalence of Haemophilus influenzae with resistant genes isolated from young children with acute lower respiratory tract infections in Nha Trang Vietnam. J Infect Chemother. 2008;14:349\u201353.","journal-title":"J Infect Chemother"},{"key":"2926_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10156-008-0623-2","volume":"14","author":"Y Niki","year":"2008","unstructured":"Niki Y, Hanaki H, Yagisawa M, Kohno S, Aoki N, Watanabe A, et al. The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. J Infect Chemother. 2008;14:279\u201390.","journal-title":"J Infect Chemother"},{"key":"2926_CR11","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10096-009-0727-3","volume":"28","author":"SS Jean","year":"2009","unstructured":"Jean SS, Hsueh PR, Lee WS, Chang HT, Chou MY, Chen IS, et al. Nationwide surveillance of antimicrobial resistance among Haemophilus influenzae and Streptococcus pneumoniae in intensive care units in Taiwan. Eur J Clin Microbiol Infect Dis. 2009;28:1013\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2926_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1017\/S0950268812001082","volume":"141","author":"SM Bae","year":"2013","unstructured":"Bae SM, Lee JH, Lee SK, Yu JY, Lee SH, Kang YH. High prevalence of nasal carriage of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae in healthy children in Korea. Epidemiol Infect. 2013;141:481\u20139.","journal-title":"Epidemiol Infect"},{"key":"2926_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhin.2009.10.021","volume":"74","author":"CJ Yang","year":"2010","unstructured":"Yang CJ, Chen TC, Wang CS, Wang CY, Liao LF, Chen YH, et al. Nosocomial outbreak of biotype I, multidrug-resistant, serologically non-typeable Haemophilus influenzae in a respiratory care ward in Taiwan. J Hosp Infect. 2010;74:406\u20139.","journal-title":"J Hosp Infect"},{"key":"2926_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jiph.2019.11.003","volume":"13","author":"S Yamada","year":"2020","unstructured":"Yamada S, Seyama S, Wajima T, Yuzawa Y, Saito M, Tanaka E, et al. beta-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance. J Infect Public Health. 2020;13:497\u2013501.","journal-title":"J Infect Public Health"},{"key":"2926_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fpubh.2020.00095","volume":"8","author":"XX Li","year":"2020","unstructured":"Li XX, Xiao SZ, Gu FF, He WP, Ni YX, Han LZ. Molecular Epidemiology and Antimicrobial Resistance of Haemophilus influenzae in Adult Patients in Shanghai China. Front Public Health. 2020;8:95.","journal-title":"Front Public Health"},{"key":"2926_CR16","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(80)91980-7","volume":"2","author":"I Braveny","year":"1980","unstructured":"Braveny I, Machka K. Multiple resistant Haemophilus influenzae and parainfluenzae in West Germany. Lancet. 1980;2:752\u20133.","journal-title":"Lancet"},{"key":"2926_CR17","unstructured":"WHO: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. 2017."},{"key":"2926_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S0140-6736(75)91630-X","volume":"1","author":"AA Medeiros","year":"1975","unstructured":"Medeiros AA, O\u2019Brien TF. Ampicillin-resistant Haemophilus influenzae type B possessing a TEM-type beta-lactamase but little permeability barrier to ampicillin. Lancet. 1975;1:716\u20139.","journal-title":"Lancet"},{"key":"2926_CR19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(81)91214-9","volume":"2","author":"LG Rubin","year":"1981","unstructured":"Rubin LG, Medeiros AA, Yolken RH, Moxon ER. Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase. Lancet. 1981;2:1008\u201310.","journal-title":"Lancet"},{"key":"2926_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12866-020-01785-9","volume":"20","author":"PY Su","year":"2020","unstructured":"Su PY, Huang AH, Lai CH, Lin HF, Lin TM, Ho CH. Extensively drug-resistant Haemophilus influenzae - emergence, epidemiology, risk factors, and regimen. BMC Microbiol. 2020;20:102.","journal-title":"BMC Microbiol"},{"key":"2926_CR21","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1128\/AAC.45.6.1693-1699.2001","volume":"45","author":"K Ubukata","year":"2001","unstructured":"Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, et al. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 2001;45:1693\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2926_CR22","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/AAC.46.7.2208-2218.2002","volume":"46","author":"H Dabernat","year":"2002","unstructured":"Dabernat H, Delmas C, Seguy M, Pelissier R, Faucon G, Bennamani S, et al. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother. 2002;46:2208\u201318.","journal-title":"Antimicrob Agents Chemother"},{"key":"2926_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/mdr.2018.0342","volume":"25","author":"MS Han","year":"2019","unstructured":"Han MS, Jung HJ, Lee HJ, Choi EH. Increasing Prevalence of Group III Penicillin-Binding Protein 3 Mutations Conferring High-Level Resistance to Beta-Lactams Among Nontypeable Haemophilus influenzae Isolates from Children in Korea. Microb Drug Resist. 2019;25:567\u201376.","journal-title":"Microb Drug Resist"},{"key":"2926_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/jac\/37.4.737","volume":"37","author":"PA James","year":"1996","unstructured":"James PA, Lewis DA, Jordens JZ, Cribb J, Dawson SJ, Murray SA. The incidence and epidemiology of beta-lactam resistance in Haemophilus influenzae. J Antimicrob Chemother. 1996;37:737\u201346.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"2926_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/jac\/48.suppl_1.87","volume":"48","author":"DM Livermore","year":"2001","unstructured":"Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother. 2001;48(Suppl 1):87\u2013102.","journal-title":"J Antimicrob Chemother"},{"key":"2926_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/jac\/dkg107","volume":"51","author":"K Straker","year":"2003","unstructured":"Straker K, Wootton M, Simm AM, Bennett PM, MacGowan AP, Walsh TR. Cefuroxime resistance in non-beta-lactamase Haemophilus influenzae is linked to mutations in ftsI. J Antimicrob Chemother. 2003;51:523\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"2926_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/jac\/dkq425","volume":"66","author":"MC Roberts","year":"2011","unstructured":"Roberts MC, Soge OO, No DB. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis. J Antimicrob Chemother. 2011;66:100\u20134.","journal-title":"J Antimicrob Chemother"},{"key":"2926_CR28","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1093\/jac\/dkx114","volume":"72","author":"S Seyama","year":"2017","unstructured":"Seyama S, Wajima T, Suzuki M, Ushio M, Fujii T, Noguchi N. Emergence and molecular characterization of Haemophilus influenzae harbouring mef(A). J Antimicrob Chemother. 2017;72:948\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2926_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","volume":"65","author":"I Chopra","year":"2001","unstructured":"Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65:232\u201360 (second page, table of contents).","journal-title":"Microbiol Mol Biol Rev"},{"key":"2926_CR30","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3201\/eid2008.140341","volume":"20","author":"SC Kuo","year":"2014","unstructured":"Kuo SC, Chen PC, Shiau YR, Wang HY, Lai JFs, Huang W, et al. Levofloxacin-resistant haemophilus influenzae, Taiwan, 2004\u20132010. Emerg Infect Dis. 2014;20:1386\u201390.","journal-title":"Emerg Infect Dis"},{"key":"2926_CR31","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1086\/420820","volume":"38","author":"J Nazir","year":"2004","unstructured":"Nazir J, Urban C, Mariano N, Burns J, Tommasulo B, Rosenberg C, et al. Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. Clin Infect Dis. 2004;38:1564\u20139.","journal-title":"Clin Infect Dis"},{"key":"2926_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/jac\/dki488","volume":"57","author":"JM Rodriguez-Martinez","year":"2006","unstructured":"Rodriguez-Martinez JM, Lopez L, Garcia I, Pascual A. Characterization of a clinical isolate of Haemophilus influenzae with a high level of fluoroquinolone resistance. J Antimicrob Chemother. 2006;57:577\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"2926_CR33","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1128\/AAC.00192-09","volume":"53","author":"Y Hirakata","year":"2009","unstructured":"Hirakata Y, Ohmori K, Mikuriya M, Saika T, Matsuzaki K, Hasegawa M, et al. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions. Antimicrob Agents Chemother. 2009;53:4225\u201330.","journal-title":"Antimicrob Agents Chemother"},{"key":"2926_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1128\/JCM.01561-07","volume":"46","author":"S Yokota","year":"2008","unstructured":"Yokota S, Ohkoshi Y, Sato K, Fujii N. Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children. J Clin Microbiol. 2008;46:361\u20135.","journal-title":"J Clin Microbiol"},{"key":"2926_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jiac.2013.12.007","volume":"20","author":"H Shoji","year":"2014","unstructured":"Shoji H, Shirakura T, Fukuchi K, Takuma T, Hanaki H, Tanaka K, et al. A molecular analysis of quinolone-resistant Haemophilus influenzae: validation of the mutations in Quinolone Resistance-Determining Regions. J Infect Chemother. 2014;20:250\u20135.","journal-title":"J Infect Chemother"},{"key":"2926_CR36","doi-asserted-by":"publisher","first-page":"896823","DOI":"10.3389\/fcimb.2022.896823","volume":"12","author":"PC Lindemann","year":"2022","unstructured":"Lindemann PC, Mylvaganam H, Oppegaard O, Anthonisen IL, Zecic N, Skaare D. Case Report: Whole-Genome Sequencing of Serially Collected Haemophilus influenzae From a Patient With Common Variable Immunodeficiency Reveals Within-Host Evolution of Resistance to Trimethoprim-Sulfamethoxazole and Azithromycin After Prolonged Treatment With These Antibiotics. Front Cell Infect Microbiol. 2022;12:896823.","journal-title":"Front Cell Infect Microbiol"},{"key":"2926_CR37","doi-asserted-by":"publisher","first-page":"944 e941","DOI":"10.1016\/j.cmi.2019.11.022","volume":"26","author":"Y Sierra","year":"2020","unstructured":"Sierra Y, Tubau F, Gonzalez-Diaz A, Carrera-Salinas A, Moleres J, Bajanca-Lavado P, et al. Assessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp. Clin Microbiol Infect. 2020;26:944 e941-944 e947.","journal-title":"Clin Microbiol Infect"},{"key":"2926_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad137","author":"WHSW Cheng","year":"2023","unstructured":"Cheng WHSW, Wen MY, Su PY, Ho CH. Molecular characterization of cefepime and aztreonam nonsusceptibility in Haemophilus influenzae. J Antimicrob Chemother. 2023. https:\/\/doi.org\/10.1093\/jac\/dkad137.","journal-title":"J Antimicrob Chemother"},{"key":"2926_CR39","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"2926_CR40","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"2926_CR41","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320.","journal-title":"Bioinformatics"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-023-02926-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-023-02926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:07:12Z","timestamp":1688548032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-023-02926-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2926"],"URL":"https:\/\/doi.org\/10.1186\/s12866-023-02926-6","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"2 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (No. 2021009) and performed at E-DA Hospital in accordance with the ethical standards noted in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consents were waived by the Institutional Review Board of E-DA Hospital because the study involved no more than minimal risk of harm to subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}